Novavax, Inc. (NVAX) Reports In-Line Q2 EPS

Novavax, Inc. (NASDAQ: NVAX) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $6.68 million.

For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• UBS Reiterates Buy Rating on PVH Corp (PVH) on Strong Earnings Growth Potential
• Change in Nonfarm Payrolls (Aug) 162K vs 55K Expected, Unemployment Rate 4.1%